Skip to main content
. Author manuscript; available in PMC: 2020 May 26.
Published in final edited form as: Curr Opin Cell Biol. 2020 Feb 21;63:135–143. doi: 10.1016/j.ceb.2020.01.005

Figure 1. Tissue specificityspecificity of cancer driver genes.

Figure 1

For each tumor type representative mutated cancer driver genes are shown including genes acting in the RAS/MAPK pathway, immune evasion and genome instability. Lung cancers refer to NSCLC (non–small-cell lung cancer) either adeno-carcinoma (LUAD) or squamous cell carcinoma (LUSC) as indicated. *: germline only.